The new drugs target very specific subsets of patients with the disease and will come with gene tests to pluckout which patients are likely to respond.
Dirks showed that some of the immature-looking cells from his patients could form tumorlike clumps in the test tube, unlike most other cells from the tumors, but he didn't have a method to pluckout the stem cells.